ETFMG Treatments Testing ... (GERM)
AMEX: GERM
· Real-Time Price · USD
19.16
-0.05 (-0.28%)
At close: Sep 05, 2024, 7:53 PM
-0.28% (1D)
| Bid | - |
| Market Cap | 9.59M |
| AUM | 9.68M |
| NAV | 19.34 |
| EPS (ttm) | 2.57 |
| PE Ratio (ttm) | 7.45 |
| Shares Out | 500.4K |
| Inception Date | Jun 18, 2020 |
| Ask | - |
| Volume | 4.83K |
| Open | 19.28 |
| Previous Close | 19.21 |
| Day's Range | 19.16 - 19.28 |
| 52-Week Range | 16.32 - 20.20 |
| Holdings | 57 |
| Expense Ratio | 0.68% |
About GERM
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Asset Class Equity
Ticker Symbol GERM
Inception Date Jun 18, 2020
Provider ETFMG
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 54.55% of assets
| Name | Symbol | Weight |
|---|---|---|
| Alnylam Pharmaceutic... | ALNY | 11.39% |
| Laboratory Corporati... | LH | 7.20% |
| Quest Diagnostics In... | DGX | 6.61% |
| Biontech Se | BNTX | 5.01% |
| Bio-rad Laboratories... | BIO | 4.74% |
| Vaxcyte, Inc. | PCVX | 4.52% |
| Quidelortho Corporat... | QDEL | 4.11% |
| Biocryst Pharmaceuti... | BCRX | 3.70% |
| Immunocore Holdings ... | IMCR | 3.67% |
| Zai Lab Limited | ZLAB | 3.60% |
Dividends Dividend Yield 1.28%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 27, 2024 | $0.0880 | Jun 28, 2024 |
| Mar 26, 2024 | $0.0558 | Mar 28, 2024 |
| Dec 27, 2023 | $0.0522 | Dec 29, 2023 |
| Sep 20, 2023 | $0.0400 | Sep 22, 2023 |
| Jun 21, 2023 | $0.0600 | Jun 23, 2023 |
